Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Arthritis Rheumatol. 2014 Jan;66(1):152–162. doi: 10.1002/art.38225

Figure 1.

Figure 1

Balb/c Caspase-1 −/− mice have intact peritoneal inflammatory responses to pristane injection but display decreased autoantibody, inflammatory cytokine and chemokine synthesis. A and B. Wild-type (WT) (n=4 PBS, n=10 pristane) and Caspase-1 −/− (n=5 PBS, n=11 pristane) peritoneal fluid was harvested 2 weeks post pristane or PBS injection. A. Total cell numbers were counted and are plotted as mean+SEM cell number per ml of peritoneal fluid removed. B. Cell populations were quantified by flow cytometry and are expressed as percentage of the total cell population when 1x106 total cells are examined. C. Results represent quantification of antibody titers by ELISA of sera from wild-type (WT) Balb/c or Balb/c caspase-1 −/− mice six months post exposure to PBS or pristane. Each dot represents a single mouse and mean +/− SEM is plotted. PBS WT n=6, PBS −/− n=11, Pristane WT n=13, Pristane −/− n=24. D. Plasma cytokine and chemokine concentrations from mice described in (C) were quantified on undiluted samples using Milliplex. Bars represent the mean +SEM. PBS WT n=6, PBS −/− n=11, Pristane WT n=13, Pristane −/− n=24. *=p<0.05, **=p<0.01, ***=p<0.001. PR=pristane